Satisfactory remission in a case of IgD myeloma: Effectiveness of glucocorticoid treatment

American Journal of Hematology

Volumn 66, Issue 1, 2001, Pages 62-63

  Takemori, Nobuo ^a   Kondo, Keiichi ^a   Kawamura, Takahito ^a   Imai, Kiyotoshi ^a   Sakurai, Hiroharu ^a   Sato, Teiko ^a  

^a Asahikawa Kosei Hospital   (Japan)

Author keywords

Complete remission; Glucocorticoid; IgD myeloma; Treatment

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN D; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DRUG EFFICACY; FEMALE; HUMAN; MYELOMA; PRIORITY JOURNAL; REMISSION; SURVIVAL TIME;

EID: 0035187794     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200101)66:1<62::aid-ajh1012>3.0.co;2-%23     Document Type: Article

References (10)

1. Plasma cell myeloma with D-myeloma protein (IgD Myeloma)
2. IgD multiple myeloma
3. Prognostic factors in IgD myeloma: A study of 21 cases
4. A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients
5. Immunoglobulin D multiple myeloma: Presenting features, response to therapy, and survival in a series of 53 cases
6. Management of refractory myeloma: A review
7. Primary dexamethasone treatment of multiple myeloma
8. Glucocorticoid receptor in multiple myeloma
9. Glucocorticoid effects on myeloma cells in culture: Correlation of growth inhibition with induction of glucocorticoid receptor messenger RNA
10. Effect of glucocorticoids on the biologic activities of myeloma cells: Inhibition of interleukin-1β osteoclast activating factor-induced bone resorption